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1. INTRODUCTION 
Following tsisolation hypothalamic extracts [l] 
the tetradecapeptide somatostatin (SS-14) has 
been found to be widely distributed throughout 
the central nervous system [2], the gastrointestinal 
tract and the pancreas [3]. Evidence for synthesis 
of SS-14 by cerebral ce ls inculture has also been 
reported (4,5]. We report here that neurons from 
chick embryo cerebral hemispheres, cultured in 
serum-free medium, are able to synthetize and to 
release two distinct molecular forms of somato- 
statin: o eis identical to SS-14 and the other has a
similar Mr-value to, but different from SS-28, an
amino-terminally extended peptide from SS- 14 [6]. 
2. MATERIALS AND METHODS 
2.1. Cultures 
Pure cultures of neurons were obtained by the 
method earlier d scribed [7]. Cerebral hemispheres 
of 8 day-old chick embryos were dissociated into
single cells, plated onpolylysine-coated dishes ata
density of 7to 8. 104 cells/cm2 andmaintained in 
vitro f r 8days in a humidified atmosphere of 95% 
air-5% CO2 at 37°C. During the first 3 days of 
culture the cells were grown in Dulbecco’s Modi- 
fied Eagle Medium (DMEM) containing 20% fetal 
calf serum (Flow Laboratories) and antibiotics (60 
U/ml of penicillin G a d 25 pg/ml of strepto- 
mycin sulphate). Fromthe 3rd to the 8th day, the 
serum-supplemented medium was replaced by a 
serum-free culture m dium 181: DMEM supple- 
mented with uman transferrin (100 mg/l), insulin 
(5 mg/l), putrescine (10-d M), sodium selenite 
(3 . 10 -8 M), progesterone (2. 10-8 M) and 17/l- 
estradiol (10 -12 M) as described in [9]. Culture 
media were changed atdays 3, 5 and 7. The cells 
and their media were collected at day 8. 
2.2. Preparation of cellular and medium extracts 
Media of 8 day-old cultures w re collected in 
acetic a id (final concentration: 3-5 M) con- 
taining iodoacetamide (0.3mg/ml) and phenyl- 
methylsulfonyl luoride (0.3 mg/ml). The cells 
were rinsed 3 times with 0.15 M NaCl at 37°C col- 
lected inthe same mixture asthe media nd ho- 
mogenized with aTeflon tissue grinder. Theprep- 
arations were then heated (95°C 15 min), centri- 
fuged (5000 rev./min, 15 min) and the superna- 
tants were lyophilized. 
2.3. Radioimmunoassay for somatostatin 
Cell and medium extracts were analysed for 
somatostatin immunoreactivity by a radioimmuno- 
assay (RIA) using anti-somatostatin antiserum 
(ref. no. 3638 SAB) raised ina rabbit mmunized 
against somatostatin covalently bound to egg al- 
bumin with glutaraldehyde. [ T r-1251]somatostatin 
was used as tracer. Theassay was performed at
4°C for 24 h in 0.05 M potassium phosphate buffer 
(pH 7.6) containing 0.15M NaCl and 0.5% bovine 
albumin. Bound and free fractions wereseparated 
by propanol precipitation nd the radioactivity 
was evaluated in a gamma-counter (70% counting 
efficiency). Underthese conditions the detection 
limit was 15 pg/tube and a 50% displacement of 
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the tracer was obtained with 40 pg of the peptide. 3. RESULTS 
Lyophilized cellular andmedium extracts were 
redissolved in cold essay buffer. Standard 
somatostatins (SS-14 and SS-28) were treated in 
the same way as the xtracts (acetic acid 3-5 M, 
iodoacetamide, PMSF heat 95°C for 15 min). No 
modification of the immunoreactive profile was 
observed in these conditions. 
2.4. Chromatography 
Somatostatin-immunoreactivity was nalyzedn 
both cellular andmedium extracts after two suc- 
cessive gelfiltrations on Sephadex G-10 and G-50 
followed by ion-exchange chromatography on 
CM-Sephadex C-25 or DEAE-Sephadex A-25. De- 
tails ofprocedures aregiven in the legends of
figs.l-3. 
The cells and the media collected at the 8th day 
of culture (24 hafter the addition of fresh medi- 
um) contained rather high amounts of immuno- 
reactive-somatostatin (IR-somatostatin): 44 f 2 
ng/ 100 mm Petri d sh, 48& 2 ng/mg protein (val- 
ues are mean + S.E. of 3 independent xperi- 
ments; n = 18 determinations). N  immunoreac- 
tive material w sdetected in serum-free culture 
medium. After Sephadex G-50 gel filtration, w  
areas of SS-immunoreactive material were ob- 
tained (fig.1) corresponding to standard SS-28 
(peak I) and SS-14 (peak II). IR-somatostatin pres- 
ent in peak Iwas not retained on CM-Sephadex C- 
25 column, suggesting a negatively charged mole- 
cule, while the immunoreactive mat rial found in 
peak II was retained an co-eluted with standard 
SS-14 (fig.2). IR-somatostatin of peak I was re- 
tained onDEAE-Sephadex A-25 column and elu- 
ted with 100 mM Tris buffer containing 0.2M
NaCl(88% of recovery), confirming thus the nega- 
tive charge ofthe molecule (fig.3). The chromato- 
graphic profile ndicates that he IR-somatostatin 
of peak Ihas a molecular weight ofabout 3000, 
but does not correspond to the SS-28 form, of the 
same molecular weight, but which is not retained 
on CM-Sephadex C-25 column. 
w/ml 
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The parallelism of nhibition curves for standard 
SS-14 or SS-28 and cellular or medium fractions 
(fig.4) suggests that the antigenic determinants re 
Fig. 1. Sephadex G-SO gel filtration of somatostatin-im- 
munoreactive material from cellular and medium ex- 
tracts. Extracts ofcells and media were desalted by
Sephadex G-10 gel filtration and lyophilized. Samples 
for chromatography were resuspended in 1ml of water 
and applied toa Biorad 0.7 X 30 cm column packed with 
Sephadex G-SO (tine, Pharmacia) and equilibrated with
0.01 M CHJCOONH~ (pH 7.4) containing 0.1% BSA 
(Fraction V, Miles). The column was eluted with the 
same buffer. 0 5 ml fractions were collected at a flow 
rate of 20 ml/h and assayed for SS by RIA. The column 
was previously calibrated with BSA (M,=63 000) and 
standard SS-14 (M, = 1600) and SS-28 (M,: 3000). The 
positions f the SS peaks were determined by RIA. Void 
volume of column: 6 ml. (O-O) culture m dium (6.9 
ng IR-somatostatin applied oncolumn); (0-0) ceils 
(65 ng IR-somatostatin applied oncolumn). 
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Fig.2. Chromatography of somatostatin-immunoreac- 
tive material from cellular extracts on CM-Sephadex C- 
25 column. Samples of peak I (corresponding to 23 ng of 
IR-somatostatin) nd peak II (corresponding to 10ng of 
IR-somatostatin) obtained bySephadex G-50 gel tiltra- 
tion of cellular extracts, were lyophilized, r suspended 
in 6 mM CH3COONH4 buffer containing 0.1% BSA 
(pH 4.7) (buffer A)and applied toa 0.6 x 10 cm column 
of CM-Sephadex C-25 equilibrated withbuffer A (flow 
rate: 20 ml/h). The column was eluted with buffer A 
and then subjected o from 6 mM (buffer A)to 600 mM 
(buffer B)CH3CHOONH4 buffer containing 0.1% BSA 
(pH 4.7):_Two ml fractions were collected an assayed 
for SS by RIA. The conductivity of each fraction wasde- 
termined. (O-O) SS-like immunoreactive material of
the cellular extracts; (O-O) conductivity. 
similar in both molecular entities of IR-somato- 
statin. Moreover, treatment of he immunoreactive 
material ofpeak I with sodium dodecyl sulfate 
(SDS, 0.5% in 1 M acetate for 1 h at 60°C) fol- 
lowed by Sephadex G-50 gel filtration, yielded a 
unique peak of IR-somatostatin wh ch eluted at 
FRACTION (2ml) 
Fig.3. Chromatography on DEAE-Sephadex A-25 of the 
IR-somatostatin of peak I obtained bySephadex G-50 
gel filtration. Samples of peak I corresponding to 5 ng of 
IR-somatostatin were dissolved in 30 mM Tris-HCl 
(pH 8.8) (buffer C)and applied toa 0.6 X 10 cm col- 
umn packed with DEAE-Sephadex A-25 equilibrated in 
buffer C.The column was washed (20 ml/h) with buffer 
C, then eluted by 100 mM Tris-HCl (pH 8.5) con- 
taining 0.2 M NaCl (buffer D). Two ml fractions were 
collected an assayed for SS by RIA. 
the same position as the untreated molecule, sug- 
gesting that peak Iis not formed by aggregated SS.
Peak II/Peak I (ratio ofthe concentrations) was 
0.5 in the cells and 2.5 in the medium. 
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Fig.4. Inhibition curves for cellular andmedium extracts 
in SS RIA system. Note parallelism of inhibition curves 
for standard somatostatins and the extracts. N.B.: stan- 
dard SS-14 and SS-28 have been treated inthe same 
way as the extracts. (A-.) standard SS-14; (m-m) 
standard SS-28; (e-e) medium extracts: (O-O) cellu- 
lar extracts. 
4. DISCUSSION 
We have previously hown that dissociated neu-
rons from chick embryo cerebral hemipsheres 
could be maintained inculture without any other 
cell type [7]. These neurons undergo maturation in 
vitro and exhibit ultrastructural and biochemical 
properties comparable tothat of adult neurons in 
vivo [ 10,111. Theuse of chemically defined culture 
media, without serum, offers favourable conditions 
to study the production of peptides bythese cul- 
tures and their elease into the medium: con- 
tamination by peptides present inthe serum and 
effects of factors contained inthe serum are thus 
avoided. 
It was noteworthy that hese neurons, originat- 
ing from the cerebral hemispheres, were able to 
synthetize andto release rather high quantities of 
SS-like immunoreactive material. When compared 
to the production of IR-somatostatin by rat cere- 
bral cells inculture [4], itappears that he amount 
of peptide released into the culture m dium is 
much higher in our experimental conditions. This 
may be explained ither bya higher rate of syn- 
thesis orrelease or by a lower ate of breakdown of 
the released SS, since the serum-free medium we 
use is devoid of peptidases usually present inthe 
serum. In addition toSS, the presence ofLeu-en- 
kephalin, Met-enkephalin andsubstance P could 
be demonstrated, although atlower levels, while fi- 
endorphin, TRH, LH-RH and ACTH could not be 
detected (in preparation). 
Two molecular forms of IR-somatostatin could 
be identified: (i) the first elutes with standard SS- 
14 on Sephadex G-50 column and has already 
been described in rat cerebral [4] and hypothal- 
amic [S] cells in culture; (ii) the second corre- 
sponds to a new molecular form of SS, of higher 
molecular weight (= 3000) and elutes inthe area 
of SS-28, the amino terminally extended form of 
SS-14 recently identified n ovine hypothalamus 
[6,12,13] and in porcine gut [6]. However, the be- 
haviour ofthis compound (negatively charged) on
ion-exchange chromatography columns differs 
from that of SS-28, suggesting structural dif- 
ferences. Theratio of the quantities of the 2 mo- 
lecular forms of SS in the cells and in the culture 
medium indicates hat he high molecular weight 
form is preferentially retained within the cells. One 
might expect that his new molecular entity ofSS 
produced bycultured neurons plays aphysiologi- 
cal role in the processes of maturation of the neu- 
rons. Work is in progress todetermine the bio- 
logical ctivities of this new molecular entity and 
to define its relationship withthe classical SS-14 
form. 
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